Latest Articles
Adjuvant Chemoradiotherapy Provides Long-Term Survival Benefits in High-Risk Endometrial Cancer - OncLive
Adjuvant Chemoradiotherapy Provides Long-Term Survival Benefits in High-Risk Endometrial Cancer OncLive
Published: Dec. 22, 2025, 5:26 a.m.
Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer - OncLive
Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer OncLive
Published: Oct. 15, 2025, 5:46 p.m.
Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes - The ASCO Post
Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes The ASCO Post
Published: Sept. 19, 2025, 2:23 p.m.
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.
Background/Objectives: Rarely, primary (PriCs) or metastatic (metECs) carcinomas occur in the episiotomy site. Methods: A systematic literature review of metECs was carried out. We reviewed the PRISMA guidelines and the …
Published: Aug. 27, 2025, midnight
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer - Nature
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer Nature
Published: Aug. 18, 2025, 7:15 a.m.
Molecular profiling reduces need for radiotherapy in endometrial cancer - Contemporary OB/GYN
Molecular profiling reduces need for radiotherapy in endometrial cancer Contemporary OB/GYN
Published: June 24, 2025, 5:47 p.m.
PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer - Medical Dialogues
PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer Medical Dialogues
Published: May 21, 2025, 3 p.m.
Molecular profiling reduces need for radiotherapy in endometrial cancer - indica News
Molecular profiling reduces need for radiotherapy in endometrial cancer indica News
Published: May 5, 2025, 1:49 p.m.
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - OncLive
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer OncLive
Published: April 21, 2025, 7:21 p.m.
(PDF) Radiotherapy improves stress urinary incontinence but impairs pelvic floor function in endometrial cancer patients: a prospective cohort study - ResearchGate
(PDF) Radiotherapy improves stress urinary incontinence but impairs pelvic floor function in endometrial cancer patients: a prospective cohort study ResearchGate
Published: Feb. 2, 2025, 4:08 a.m.
Link copied to clipboard!